U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT06811246) titled 'A Clinical Study of Islatravir and Its Interaction With Lamivudine (MK-8591-058)' on Jan. 31.
Brief Summary: The goal of this study is to learn what happens to the medication islatravir (ISL), in a healthy person's body over time--called a pharmacokinetic (PK) study. Researchers want to compare the amount of islatravir in the blood when it is taken alone as a single dose and when it is taken with multiple doses of another medication called lamivudine (3TC).
Study Start Date: Feb. 07, 2024
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: Islatravir (ISL)
Oral administration of a single dose in period 1 and peri...